During the 14th Five-Year Plan (2021-25) period, the Taixing Economic Development Zone and Binjiang town adhered to an integrated development approach, yielding fruitful results.
The semaglutide active pharmaceutical ingredient manufactured by Space Peptides has successfully obtained a Drug Master File (DMF) from the U.S. Food and Drug Administration.
From January to August, Taixing achieved a foreign trade value of $5.17 billion, a year-on-year increase of 19.6 percent, indicating steady progress and improved quality and efficiency.
This year, industrial development in the zone has showed exceptional resilience and vitality, with new projects continuously being launched and sustained momentum.
China's economy drew strong support from new growth drivers in August, with double-digit growth in high-tech manufacturing and solid external demand underpinning fast industrial growth.
